Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07408154 · ClinicalTrials.gov registry record · NA
Direct vs Standard SLT for Glaucoma: A Noninferiority Trial
A NA study, sponsored by Medical University of South Carolina.
- Recruiting
- Registry status
- NA
- Development phase
- 172
- Enrollment target
NCT07408154 is a NA study that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 172 participants.
The verdict
NCT07408154, a NA study, is actively recruiting participants, sponsored by Medical University of South Carolina.
- RECRUITING
- Registry status
- NA
- Development phase
- 172 participants
- Enrollment target
Study Summary
This study compares two FDA-approved laser treatments for glaucoma: Direct Selective Laser Trabeculoplasty (DSLT) and Selective Laser Trabeculoplasty (SLT). Both procedures aim to lower eye pressure and prevent vision loss. DSLT is a newer, non-contact technique that may improve comfort and efficiency. Participants will be randomly assigned to receive either DSLT or SLT and followed for 12 months to assess eye pressure, safety, and treatment outcomes.
Interventions
- DEVICE Direct Selective laser Trabeculoplasty
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 172 participants |
| Start Date | 2026-04-27 |
| Est. Completion | 2027-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07408154
The ClinicalTrials.gov registry entry for NCT07408154 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 172 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Direct Selective laser Trabeculoplasty is the first listed.
NCT07408154 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07408154 about?
NCT07408154 is a clinical study titled "Direct vs Standard SLT for Glaucoma: A Noninferiority Trial". This study compares two FDA-approved laser treatments for glaucoma: Direct Selective Laser Trabeculoplasty (DSLT) and Selective Laser Trabeculoplasty (SLT). Both procedures aim to lower eye pressure and prevent vision loss. DSLT is a newer, non-contact technique that may improve comfort and efficien...
What is the current status of trial NCT07408154?
This trial is currently recruiting. It is a NA study. The enrollment target is 172 participants. The study started on 2026-04-27. Estimated completion is 2027-10.
What interventions are being tested in trial NCT07408154?
The interventions under investigation include: Direct Selective laser Trabeculoplasty (DEVICE).
Who is sponsoring clinical trial NCT07408154?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.